AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients

Recruitingn/aAges 50 Years - 85 YearsAllHuashan Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

In this observational study, the investigators evaluate the influencing factors of cerebrovascular disease and cognition in hemodialysis patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. maintenance hemodialysis patients who are younger than 85 years old and older than 50 years old, regardless of gender 2. dialysis vintage is greater than 3 months; Exclusion Criteria: 1. Those with severe infection and anemia (Hb \<60g / L); 2. Those with severe mental illness, metabolic diseases and immune system diseases; 3. Patients with abnormal liver function
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Huashan Hospital
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy